Comparison of Ceftizoxime Plus Ampicillin-Sulbactam versus Gentamicin Plus Ampicillin-Sulbactam in the Prevention of Post-Transplant Early Bacterial Infections in Liver Transplant Recipients: A Randomized Controlled Trial

References

• Burra P, Burroughs A, Graziadei I, et al. EASL clinical practice guidelines: liver transplantation. J Hepatol. 2016;64(2):433–485.26597456
   PubMed Web of Science ®Google Scholar
• Locke JE, Durand C, Reed RD, et al. Long-term outcomes after liver transplantation among human immunodeficiency virus infected recipients. Transplantation. 2016;100(1):141. doi:10.1097/TP.000000000000082926177090
   PubMed Web of Science ®Google Scholar
• Nikeghbalian S, Aliakbarian M, Kazemi K, et al. Clinical experience in organ transplant from the Shiraz Transplant Center: 2011. Exp Clin Transplant. 2012;10(4):307–309. doi:10.6002/ect22845762
   PubMed Web of Science ®Google Scholar
• Idossa DW, Simonetto DA. Infectious complications and malignancies arising after liver transplantation. Anesthesiol Clin. 2017;35(3):381–393. doi:10.1016/j.anclin.2017.04.00228784215
   PubMedGoogle Scholar
• Fishman JA. Infection in organ transplantation. Am j Transplant. 2017;17(4):856–879. doi:10.1111/ajt.1420828117944
   PubMed Web of Science ®Google Scholar
• Gotoh K, Eguchi H, Iwagumi Y, et al. The risk factors of post-transplant bacteremia in living donor liver transplantation. Transplantation. 2018;102:S879. doi:10.1097/01.tp.0000543966.44365.ac
   Google Scholar
• Kim SI. Bacterial infection after liver transplantation. World j Gastroenterol. 2014;20(20):6211–6220. doi:10.3748/wjg.v20.i20.621124876741
   PubMed Web of Science ®Google Scholar
• Hernandez MDP, Martin P, Simkins J. Infectious complications after liver transplantation. Gastroenterol Hepatol (N Y). 2015;11(11):741.27134589
   PubMedGoogle Scholar
• Kim SI, Kim YJ, Choi JY, et al. Early-onset and late-onset bacteremias after liver transplantation. Transplantation. 2018;102:S658. doi:10.1097/01.tp.0000543588.88342.2e
   Web of Science ®Google Scholar
• Kim YJ, Kim SI, Wie SH, et al. Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience. Transplant Infect Dis. 2008;10(5):316–324. doi:10.1111/tid.2008.10.issue-5
   Web of Science ®Google Scholar
• Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013;14(1):73–156. doi:10.1089/sur.2013.999923461695
   PubMed Web of Science ®Google Scholar
• Nikeghbalian S, Kakaei F, Kazemi K, et al. Comparison of two antibiotic prophylaxis regimens in liver transplant recipients: a randomized clinical trial: 337. Transplantation. 2010;90:803. doi:10.1097/00007890-201007272-01564
   Google Scholar
• Venkataraman R, Kellum JA. Defining acute renal failure: the RIFLE criteria. J Intensive Care Med. 2007;22(4):187–193. doi:10.1177/088506660729951017712054
   PubMedGoogle Scholar
• Becker B, Cooper MA. Aminoglycoside antibiotics in the 21st century. ACS Chem Biol. 2013;8(1):105–115. doi:10.1021/cb300511623110460
   PubMed Web of Science ®Google Scholar
• CLSI C. Performance Standards for Antimicrobial Susceptibility Testing. Clinical Lab Standards Institute; 2016.
   Google Scholar
• Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332. doi:10.1016/j.ajic.2008.03.00218538699
   PubMed Web of Science ®Google Scholar
• Almeida RA, Hasimoto CN, Kim A, Hasimoto EN, El Dib R. Antibiotic prophylaxis for surgical site infection in people undergoing liver transplantation. Cochrane Database Syst Rev. 2015;(12). doi:10.1002/14651858.CD010164.pub2
   Web of Science ®Google Scholar
• Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med. 2012;27(2):128–142. doi:10.3904/kjim.2012.27.2.12822707882
   PubMed Web of Science ®Google Scholar
• Wan QQ, Ye QF, Yuan H. Multidrug-resistant gram-negative bacteria in solid organ transplant recipients with bacteremias. Eur j Clin Microbiol Infect Dis. 2015;34(3):431–437. doi:10.1007/s10096-014-2271-z25388855
   PubMed Web of Science ®Google Scholar
• Linares L, Garcia-Goez JF, Cervera C, et al. Early bacteremia after solid organ transplantation. Transplant Proc 2009;41(6):2262–2264. doi:10.1016/j.transproceed.2009.06.079
   Google Scholar
• Anvarinejad M, Japoni A, Davarpanah MA, Mahmudi H, Mammina C, Vazin A. Phenotypic and molecular epidemiology of acinetobacter calcoaceticus baumannii complex strains spread at Nemazee Hospital of Shiraz, Iran. Jundishapur j Microbiol. 2015;8:6. doi:10.5812/jjm
   Web of Science ®Google Scholar
• Singh A, Govil D, Baveja UK, et al. Epidemiological analysis of extended-spectrum beta-lactamase-producing bacterial infections in adult live donor liver transplant patients. Indian j Crit Care Med. 2018;22(4):290–296. doi:10.4103/ijccm.IJCCM_206_1729743768
   PubMed Web of Science ®Google Scholar
• Asensio A, Ramos A, Cuervas‐Mons V, et al. Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant. Liver Transplant. 2008;14(6):799–805. doi:10.1002/lt.21435
   Web of Science ®Google Scholar
• Garcia Prado ME, Matia EC, Ciuro FP, et al. Surgical site infection in liver transplant recipients: impact of the type of perioperative prophylaxis. Transplantation. 2008;85(12):1849–1854. doi:10.1097/TP.0b013e318173540718580480
   PubMed Web of Science ®Google Scholar
• Krause KM, Serio AW, Kane TR, Connolly LE. Aminoglycosides: an overview. Cold Spring Harb Perspect Med. 2016;6:6. doi:10.1101/cshperspect.a027029
   Web of Science ®Google Scholar
• Vazin A, Japoni A, Shahbazi S, Davarpanah MA. Vancomycin utilization evaluation at hematology-oncology ward of a teaching hospital in Iran. Iran J Pharm Res. 2012;11(1):163–170.24250438
   PubMed Web of Science ®Google Scholar
• Pouladfar G, Jafarpour Z, Malek Hosseini SA, Firoozifar M, Rasekh R, Khosravifard L. Bacterial infections in pediatric patients during early post liver transplant period: a prospective study in Iran. Transplant Infect Dis. 2019;21(1):e13001. doi:10.1111/tid.2019.21.issue-1
   Web of Science ®Google Scholar
• Fishman JA, Issa NC. Infection in organ transplantation: risk factors and evolving patterns of infection. Infect Dis Clin North Am. 2010;24(2):273–283. doi:10.1016/j.idc.2010.01.00520466270
   PubMed Web of Science ®Google Scholar
• Destache CJ. Aminoglycoside-induced nephrotoxicity–a focus on monitoring: a review of literature. J Pharm Pract. 2014;27(6):562–566. doi:10.1177/089719001454610225124375
   PubMedGoogle Scholar
• Peloquin CA, Berning SE, Nitta AT, et al. Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis. 2004;38(11):1538–1544. doi:10.1086/42074215156439
   PubMed Web of Science ®Google Scholar
• Nielsen DV, Fedosova M, Hjortdal V, Jakobsen CJ. Is single-dose prophylactic gentamicin associated with acute kidney injury in patients undergoing cardiac surgery? A matched-pair analysis. J Thorac Cardiovasc Surg. 2014;148(4):1634–1639. doi:10.1016/j.jtcvs.2014.05.09025150580
   PubMed Web of Science ®Google Scholar